Placebo-Controlled Trial of Pharmaceutical Optimized Hydralazine 25mg (F-6) in Patients with Essential Hypertension. (2024). Medical Forum Monthly, 30(5). https://medicalforummonthly.com/index.php/mfm/article/view/3666